Search Results - "Dirmesropian, S"

Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy by Dirmesropian, S, Liu, B, Wood, J G, MacIntyre, C R, McIntyre, P, Karki, S, Jayasinghe, S, Newall, A T

“…Community-acquired pneumonia (CAP) results in substantial numbers of hospitalisations and deaths in older adults. There are known lifestyle and medical risk…”
Get full text

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians by Dirmesropian, S., Wood, J.G., MacIntyre, C.R., Beutels, P., McIntyre, P., Menzies, R., Reyes, J.F., Chen, C., Newall, A.T.

“…The 23-valent pneumococcal polysaccharide vaccine (PPV23) has been funded under the Australia National Immunisation Program (NIP) since January 2005 for those…”
Get full text

The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia by Chen, C., Wood, J.G., Beutels, P., Menzies, R., MacIntyre, C.R., Dirmesropian, S., Reyes, J.F., McIntyre, P., Newall, A.T.

“…While the impact of the timeliness of vaccine administration has been well-studied for childhood vaccinations, there has been little detailed quantitative…”
Get full text

A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly by Dirmesropian, S, Wood, JG, MacIntyre, CR, Newall, AT

“…The 13-valent pneumococcal conjugated vaccine (PCV13) is already recommended for some adult groups and is being considered for wider use in many countries. In…”
Get full text